Pyramidion Technology Group, Inc. (OTC: PYTG) Bolsters Advisory Board by Appointing Dr. Michael McKenzie

WESTON, Florida, September 13, 2018 /PRNewswire/ — Pyramidion Technology Group, Inc. (OTC: PYTG) today announces that Dr. Michael McKenzie is the most recent addition to the company’s Board of Advisors.


Dr. Michael McKenzie, MD specializes in family medicine and approaches healthcare with the individual person in mind. In reference to his medical practice, Dr. McKenzie states “I view each patient as a unique opportunity to consult, care for, and address their individual health-care needs. At times, this involves a holistic approach to healthcare and leads to non-prescription drug choices. I view cannabis, in many forms, such as CBD in oil [Cannabidiol] and in other delivery methods, as recently chartered waters with a myriad of potential benefits.”


Dr. McKenzie’s contributions to the dialogues taking place amongst the medical professionals serving on the Advisory Board for PYTG are expected to steer the course of product planning towards individually-catered formulas and addressing the needs of particular case types. Given Dr. McKenzie’s focus on the individual patient and the time he dedicates to his patients along with his understanding of the human body and mind, the Advisory Board is excited to explore his input and feedback on product designs, formulas, and delivery methods.


CEO of PYTG, Carlos Hurtado, explains that, “We are seeking to bolster our already strong Advisory Board with physicians that sincerely care for their patients and who are looking out for their patients’ best interests. Dr. McKenzie does exactly that – he approaches family care in an organic, ground-up manner, with a constant focus on the patients themselves. During our interactions with Dr. McKenzie, his dedication to his patients and his diligence for providing top-quality medical care is clearly of the highest priority.”


When asked “What is your opinion of the use of Cannabinoid containing products?”, Dr. McKenzie responded, “We are on the brink of something potentially life changing for many individuals and for our society as a whole. Research has demonstrated many positive effects of the use of CBD containing products and, as a community, we expect this research to continue.”


Research investigating the effects of CBD have produced positive findings thereby supporting its use in the treatment of a variety of conditions and ailments such as rheumatoid arthritis, diabetes, alcoholism, post-traumatic stress disorder, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy.


Dr. McKenzie continues, “I am truly honored to be a part of the Advisory Board for PYTG and I can foresee making contributions to the direction of product formulation based on my experience in medicine and my experience treating patients. We have something special here with LeafyWell products and I look forward to the great things to come out of our future interactions with the highly-respected and widely-recognized board members.”


The Advisory Board for PYTG is now tasked with product line formula creation, review, polishing, and perfecting as well as seeking potentially new and innovative delivery methods including restorative sports drinks, lotions, flavored oils, sweets and candies, cookies, along with many others. Dr. McKenzie’s expertise in family medicine and the patient as an individual should provide PYTG with a unique perspective related to product refining and development.


“Dr. McKenzie is exactly what we have been looking for and we are excited to bring him on board. He is someone who cares as much as we do and we trust he will make valuable contributions to the Advisory Board and the products,” explains Carlos Hurtado, CEO of PYTG.


About Pyramidion Technology Group, Inc   

Pyramidion Technology Group, Inc. (“PYTG” or the “Company”) is best described as a business incubator. The purpose of our business model is to leverage equity, to acquire, merge and or joint venture with early stage companies in emerging sectors, to facilitate growth and cash flow utilizing a diverse distribution method.


Our intention is to develop and acquire fast growing companies in up-trending industries and positioning technology for economic growth. This platform will combine natural relationships, marketing synergies and distribution methods that enable combined companies to provide a wide variety of unique and complete solutions, services and necessities to consumers. We believe our

overall business model could effectively create a company of unlimited opportunities for our growing shareholder base.


For more information on PYTG, please visit the Company’s website at

To be added to the Company investor email list, please email with PYTG in the subject line.



This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance


on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at


Phone: +1-954-329-2205

SOURCE Pyramidion Technology Group, Inc